Search

everythinglearnresearchcommunity

for

Search:↓

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Certain hormone treatments can improve acne and related conditions in women.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Hidradenitis suppurativa improves with antiandrogen therapy.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.